The Effect of Cilostazol on Rheumatoid Arthritis Patients

PHASE2/PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2024

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Cilostazol 100 MG

An antiplatelet agent used for intermittent claudication , it has an anti-inflammatory effect which will help control patients with Rheumatoid arthritis

DRUG

conventional synthetic antirheumatic drugs

methotrexate 7.5-15 mg once weekly hydroxychloroquine 200 mg twice daily sulfasalazine 500 mg to 3 g once daily leflunomide 20 mg once daily

Trial Locations (1)

Unknown

Al-Zahraa Hospital, Cairo

All Listed Sponsors
collaborator

Misr International University

OTHER

collaborator

Al-Azhar University

OTHER

lead

Ain Shams University

OTHER